Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Xuanyi Li, Ziang Ding, Zixuan Wu, Yinqiu Xu, Hequan Yao & Kejiang Lin. (2021) Targeting the TGF-β signaling pathway for fibrosis therapy: a patent review (2015–2020). Expert Opinion on Therapeutic Patents 31:8, pages 723-743.
Read now
Read now
Andrew Cowie, Fergus Noble & Timothy Underwood. (2014) Strategies to improve outcomes in esophageal adenocarcinoma. Expert Review of Anticancer Therapy 14:6, pages 677-687.
Read now
Read now
Scott Z Fields, Shiroo Parshad, Madhurima Anne, Haralambos Raftopoulos, Mark J Alexander, Matthew L Sherman, Abderrahmane Laadem, Victoria Sung & Evangelos Terpos. (2013) Activin receptor antagonists for cancer-related anemia and bone disease. Expert Opinion on Investigational Drugs 22:1, pages 87-101.
Read now
Read now
Articles from other publishers (33)
Tatyana A. Stroganova, Vladimir K. Vasilin, Victor V. Dotsenko, Nicolai A. Aksenov, Pavel G. Morozov, Pavel M. Vassiliev, Vitaly A. Volynkin & Gennady D. Krapivin. (2021)
Unusual Oxidative Dimerization in the 3-Aminothieno[2,3-
b
]pyridine-2-carboxamide Series
. ACS Omega 6:22, pages 14030-14048.
Crossref
Crossref
Yue-Yu Gu, Jing-Yun Dou, Xiao-Ru Huang, Xu-Sheng Liu & Hui-Yao Lan. (2021) Transforming Growth Factor-β and Long Non-coding RNA in Renal Inflammation and Fibrosis. Frontiers in Physiology 12.
Crossref
Crossref
Varish Ahmad. (2021) Prospective of extracellular matrix and drug correlations in disease management. Asian Journal of Pharmaceutical Sciences 16:2, pages 147-160.
Crossref
Crossref
Victor V. Dotsenko, Dmitrii S. Buryi, Darya Yu. Lukina, Angelica N. Stolyarova, Nicolai A. Aksenov, Inna V. Aksenova, Vladimir D. Strelkov & Lyudmila V. Dyadyuchenko. (2019) Substituted N-(thieno[2,3-b]pyridine-3-yl)acetamides: synthesis, reactions, and biological activity. Monatshefte für Chemie - Chemical Monthly 150:11, pages 1973-1985.
Crossref
Crossref
Marjorie Argollo, Daniela Gilardi, Giulia Roda, Gionata Fiorino, Laurent Peyrin-Biroulet & Silvio Danese. (2019) Anti-fibrotic Drugs for Crohn’s Disease: Ready for Prime Time?. Current Pharmaceutical Design 25:1, pages 47-56.
Crossref
Crossref
Wei-Qiang Tan, Qing-Qing Fang, Xiao Z Shen, Jorge F Giani, Tuantuan V Zhao, Peng Shi, Li-Yun Zhang, Zakir Khan, You Li, Liang Li, Ji-Hua Xu, Ellen A Bernstein & Kenneth E Bernstein. (2018) Angiotensin-converting enzyme inhibitor works as a scar formation inhibitor by down-regulating Smad and TGF-β-activated kinase 1 (TAK1) pathways in mice. British Journal of Pharmacology 175:22, pages 4239-4252.
Crossref
Crossref
Xin Xu, Liwei Zheng, Quan Yuan, Gehua Zhen, Janet L. Crane, Xuedong Zhou & Xu Cao. (2018) Transforming growth factor-β in stem cells and tissue homeostasis. Bone Research 6:1.
Crossref
Crossref
Hadi Khalil, Onur Kanisicak, Vikram Prasad, Robert N. Correll, Xing Fu, Tobias Schips, Ronald J. Vagnozzi, Ruijie Liu, Thanh Huynh, Se-Jin Lee, Jason Karch & Jeffery D. Molkentin. (2017) Fibroblast-specific TGF-β–Smad2/3 signaling underlies cardiac fibrosis. Journal of Clinical Investigation 127:10, pages 3770-3783.
Crossref
Crossref
S.G. Davies, P.D. Kennewell, A.J. Russell, L. Silpa, R. Westwood & G.M. Wynne. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
379
435
.
B. Hinz. (2016) The role of myofibroblasts in wound healing. Current Research in Translational Medicine 64:4, pages 171-177.
Crossref
Crossref
Richard Gilbert, Matthew Vickaryous & Alicia Viloria-Petit. (2016) Signalling by Transforming Growth Factor Beta Isoforms in Wound Healing and Tissue Regeneration. Journal of Developmental Biology 4:2, pages 21.
Crossref
Crossref
B. Hinz. 2016. Wound Healing Biomaterials. Wound Healing Biomaterials
69
100
.
W.G. Jiang, A.J. Sanders, M. Katoh, H. Ungefroren, F. Gieseler, M. Prince, S.K. Thompson, M. Zollo, D. Spano, P. Dhawan, D. Sliva, P.R. Subbarayan, M. Sarkar, K. Honoki, H. Fujii, A.G. Georgakilas, A. Amedei, E. Niccolai, A. Amin, S.S. Ashraf, L. Ye, W.G. Helferich, X. Yang, C.S. Boosani, G. Guha, M.R. Ciriolo, K. Aquilano, S. Chen, A.S. Azmi, W.N. Keith, A. Bilsland, D. Bhakta, D. Halicka, S. Nowsheen, F. Pantano & D. Santini. (2015) Tissue invasion and metastasis: Molecular, biological and clinical perspectives. Seminars in Cancer Biology 35, pages S244-S275.
Crossref
Crossref
Yaping Li, Wenjun Wang, Xiaoli Jia, Song Zhai, Xiufang Wang, Yuan Wang & Shuangsuo Dang. (2015) A Targeted Multiple Antigenic Peptide Vaccine Augments the Immune Response to Self TGF-β1 and Suppresses Ongoing Hepatic Fibrosis. Archivum Immunologiae et Therapiae Experimentalis 63:4, pages 305-315.
Crossref
Crossref
Misako Sato, Tsutomu Matsubara, Jun Adachi, Yuuki Hashimoto, Kazuna Fukamizu, Marina Kishida, Yu-an Yang, Lalage M. Wakefield & Takeshi Tomonaga. (2015) Differential Proteome Analysis Identifies TGF-β-Related Pro-Metastatic Proteins in a 4T1 Murine Breast Cancer Model. PLOS ONE 10:5, pages e0126483.
Crossref
Crossref
Daniel Längle, Viktoria Marquardt, Elena Heider, Brigita Vigante, Gunars Duburs, Iveta Luntena, Dirk Flötgen, Christopher Golz, Carsten Strohmann, Oliver Koch & Dennis Schade. (2015) Design, synthesis and 3D-QSAR studies of novel 1,4-dihydropyridines as TGFβ/Smad inhibitors. European Journal of Medicinal Chemistry 95, pages 249-266.
Crossref
Crossref
Stephen G. DaviesPeter D. KennewellAngela J. RussellPeter T. SedenRobert WestwoodGraham M. Wynne. (2015) Stemistry: The Control of Stem Cells in Situ Using Chemistry. Journal of Medicinal Chemistry 58:7, pages 2863-2894.
Crossref
Crossref
Vahab Fatourechi. (2014) Medical Management of Extrathyroidai-Man I Festation of Graves Disease. Endocrine Practice 20:12, pages 1333-1344.
Crossref
Crossref
Witek Kwiatkowski, Peter C. Gray & Senyon Choe. (2014) Engineering TGF-β superfamily ligands for clinical applications. Trends in Pharmacological Sciences 35:12, pages 648-657.
Crossref
Crossref
Song Yi Ko & Honami Naora. (2014) Therapeutic strategies for targeting the ovarian tumor stroma. World Journal of Clinical Cases 2:6, pages 194.
Crossref
Crossref
Yael Raz & Neta Erez. (2013) An inflammatory vicious cycle: Fibroblasts and immune cell recruitment in cancer. Experimental Cell Research 319:11, pages 1596-1603.
Crossref
Crossref
Hong-Feng Yuan, Hong Huang, Xiang-Yun Li, Wei Guo, Wei Xing, Zhi-Ya Sun, Hua-Ping Liang, Jian Yu, Dong-Feng Chen, Zheng-Guo Wang, Jin Hao & Xiang Xu. (2013) A Dual AP-1 and SMAD Decoy ODN Suppresses Tissue Fibrosis and Scarring in Mice. Journal of Investigative Dermatology 133:4, pages 1080-1087.
Crossref
Crossref
Carole Y. Perrot, Delphine Javelaud & Alain Mauviel. (2013) Overlapping activities of TGF-β and Hedgehog signaling in cancer: Therapeutic targets for cancer treatment. Pharmacology & Therapeutics 137:2, pages 183-199.
Crossref
Crossref
Jean-Charles Neel, Laure Humbert & Jean-Jacques Lebrun. (2012) The Dual Role of TGFβ in Human Cancer: From Tumor Suppression to Cancer Metastasis. ISRN Molecular Biology 2012, pages 1-28.
Crossref
Crossref
T C Araújo-Jorge, M C Waghabi, S Bailly & J-J Feige. (2012) The TGF-β Pathway as an Emerging Target for Chagas Disease Therapy. Clinical Pharmacology & Therapeutics 92:5, pages 613-621.
Crossref
Crossref
Rosemary J. Akhurst & Akiko Hata. (2012) Targeting the TGFβ signalling pathway in disease. Nature Reviews Drug Discovery 11:10, pages 790-811.
Crossref
Crossref
Jeroen T Buijs, Keith R Stayrook & Theresa A Guise. (2012) The role of TGF-β in bone metastasis: novel therapeutic perspectives. BoneKEy Reports 1:6.
Crossref
Crossref
Mark L. Boys, Feng Bian, James B. Kramer, Christopher L. Chio, Xiao-Dan Ren, Huifen Chen, Stephen D. Barrett, Karen E. Sexton, Donna M. Iula, Gary F. Filzen, Maria N. Nguyen, Paul Angell, Victoria L. Downs, Zhi Wang, Neil Raheja, Edmund L. Ellsworth, Stephen Fakhoury, Larry D. Bratton, Paul R. Keller, Richard Gowan, Elena M. Drummond, Samarendra N. Maiti, Mostofa A. Hena, Leroy Lu, Patrick McConnell, John D. Knafels, Venkataraman Thanabal, Fang Sun, Diane Alessi, Ann McCarthy, Erli Zhang, Barry C. Finzel, Sneha Patel, Susan M. Ciotti, Rone Eisma, N.A. Payne, Richard B. Gilbertsen, Catherine R. Kostlan, David J. Pocalyko & Deepak S. Lala. (2012) Discovery of a series of 2-(1H-pyrazol-1-yl)pyridines as ALK5 inhibitors with potential utility in the prevention of dermal scarring. Bioorganic & Medicinal Chemistry Letters 22:10, pages 3392-3397.
Crossref
Crossref
D. Focosi, F. Maggi, M. Pistello, U. Boggi & F. Scatena. (2011) Immunosuppressive monoclonal antibodies: current and next generation. Clinical Microbiology and Infection 17:12, pages 1759-1768.
Crossref
Crossref
Jeroen T. Buijs, Keith R. Stayrook & Theresa A. Guise. (2011) TGF-β in the Bone Microenvironment: Role in Breast Cancer Metastases. Cancer Microenvironment 4:3, pages 261-281.
Crossref
Crossref
Jasbir Singh, Harmeet Kaur, Aditi Kaushik & Sapna Peer. (2011) A Review of Antisense Therapeutic Interventions for Molecular Biological Targets in Various Diseases. International Journal of Pharmacology 7:3, pages 294-315.
Crossref
Crossref
Jairo Olivares, Padmasini Kumar, Yang Yu, Phillip B. Maples, Neil Senzer, Cynthia Bedell, Minal Barve, Alex Tong, Beena O. Pappen, Joseph Kuhn, Mitchell Magee, Gladice Wallraven & John Nemunaitis. (2011) Phase I Trial of TGF-β2 Antisense GM-CSF Gene-Modified Autologous Tumor Cell (TAG) Vaccine. Clinical Cancer Research 17:1, pages 183-192.
Crossref
Crossref
Elena Vasyutina & Mathias Treier. (2010) Molecular mechanisms in renal degenerative disease. Seminars in Cell & Developmental Biology 21:8, pages 831-837.
Crossref
Crossref